The function of the selective inhibitors of cycloxygenase 2

Mini-Reviews in Medicinal Chemistry

Volumn 6, Issue 12, 2006, Pages 1375-1381

  Luan, Yepeng ^a   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Anti Inflammation; Anti prostate Cancer; Celecoxib; Glaucoma; Neurological Diseases; Prostaglandin I2

Indexed keywords

4 [5 (4 BROMOPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; ACETYLSALICYLIC ACID; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; IBUPROFEN; INDOMETACIN; LUMIRACOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; OXYPHENBUTAZONE; P ROTEIN P27; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTEIN BCL 2; ROFECOXIB; VALDECOXIB;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CENTRAL NERVOUS SYSTEM; CHEMOPROPHYLAXIS; COGNITIVE DEFECT; COLON CANCER; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HUMAN; IMMUNE RESPONSE; NEUROLOGIC DISEASE; NONHUMAN; OSTEOARTHRITIS; PROSTAGLANDIN SYNTHESIS; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; TUMOR VASCULARIZATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; GLAUCOMA; HUMANS;

EID: 33845382779     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955706778992969     Document Type: Review

References (21)

1. Paola, P.; Stefania, T.; Maria, G.S, Capone, M.L. Brain Res. Rev. 2005, 48, 352.
2. Amra, A.-G.E.; Abdulla, M.M. Bioorg. Med. Chem. 2006, 14, 4341.
3. Alexander, W.; Angela, C.; Andreas, H.; Daniel, K.; Supuran, C.T.; Andrea, S.; Gerhard, K. J. Med. Chem. 2004, 47, 550.
4. Subbaramaiah, K.; Dannenberg, A.J. Trends Pharmacol. Sci. 2003, 24(2), 96.
5. Katori, M.; Majima, M. Inflamm. Res. 2000, 49, 367.
6. Ulrich, C.M. Bigler, J.; Potter, J.D. Nature 2006, 6, 130.
7. Hull, M.A. Eur. J. Cancer 2005, 41, 1854.
8. Dorai, T.; Sawczuk, I.S.; Pastorek, J.; Wiernik, P.H.; Dutcher, J.P. Eur. J. Cancer 2005, 41, 2935.
9. Kirschenbaum, A.; Liu, X.-H.; Yao, S.; Levine, A.C. Urology 2001, 58, 127.
10. Hussain, T.; Gupta, S.; Mukhtar, H. Cancer Lett. 2003, 191, 125.
11. Kashfi, K.; Rigas, B. Biochem. Pharmacol. 2005, 70, 969.
12. Kawai, N.; Tsujii, M.; Tsuji, S. Prostaglandins Other Lipid Mediat. 2002, 68-69, 187.
13. Takahashia, T.; Babaa, M.; Nishinob, H.; Okuyamaa, T. Cancer Lett. 2006, 231, 319.
14. Davies, G.L.S. J. Steroid Biochem. Mole. Biol. 2003, 86, 495.
15. Singh, B.; Lucci, A. J. Surgical Res. 2002, 108, 173.
16. Yukio, H.; Tomoyuki, Y.; Yuko, H.; Ryu, N.; Kanji, N.; Yutaka, N.; Atsushi, O. Lung Cancer 2000, 30, 73.
17. Kim, H.J.; Wu, H.-G.; Park, I.A.; Ha, S.W. Int. J. Radiat. Oncol. Biol. Phys. 2003, 55, 16.
18. Muller, N.; Riedel, M.; Schwarz, M.J. Pharmacopsychiatry 2004, 37, 266.
19. Hoffmann, C. Cur. Med. Chem. 2000, 7, 1113.
20. Firuzi, O.; Pratico, D. Ann. Neurol. 2006, 59, 219.
21. Wang, X.-H.; Li, S.-B.; Tong, Q.; Xie, G.-J.; Wu, Q.-M. World J. Gastroenterol. 2005, 1139, 6110.